29BF Lu, Bo - Thomas Jefferson University - Thomas Jefferson University
bxl017

Bo Lu, MD

Contact Dr. Lu

G-301 Bodine Cancer Center
111 S. 11th Street
Philadelphia, PA 19107

(215) 955-6705
(215) 503-0013 fax

Most Recent Peer-reviewed Publications

  1. Heat shock protein 90 inhibition: Rationale and clinical potential
  2. Role of insulin-like growth factor-1 signaling pathway in cisplatin-resistant lung cancer cells
  3. Cell cycle and vascular targets for radiotherapy
  4. The zinc ionophore PCI-5002 radiosensitizes non-small cell lung cancer cells by enhancing autophagic cell death
  5. MLN8054, A small molecule inhibitor of Aurora kinase A, sensitizes androgen-resistant prostate cancer to radiation
  6. Editorial: Cancer stem cells
  7. No evidence for association of the MDM2-309 T/G promoter polymorphism with prostate cancer outcomes
  8. Inhibition of JAK2 signaling by TG101209 enhances radiotherapy in lung cancer models
  9. The matrix metalloproteinase-7 polymorphism RS10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer
  10. Enhanced radiosensitivity of androgen-resistant prostate cancer: AZD1152-mediated aurora kinase B inhibition
  11. Terameprocol (tetra-o-methyl nordihydroguaiaretic acid), an inhibitor of Sp1-mediated survivin transcription, induces radiosensitization in non-small cell lung carcinoma
  12. Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis
  13. Enzastaurin (LY317615), a protein kinase C beta selective inhibitor, enhances antiangiogenic effect of radiation
  14. Endoplasmic reticulum stress mediates radiation-induced autophagy by perk-eIF2α in caspase-3/7-deficient cells
  15. Progress in the unraveling of the endoplasmic reticulum stress/autophagy pathway and cancer: Implications for future therapeutic approaches
  16. AT-101, a Pan-Bcl-2 inhibitor, leads to radiosensitization of non-small cell lung cancer
  17. The EGFR Polymorphism rs884419 is Associated With Freedom From Recurrence in Patients With Resected Prostate Cancer
  18. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer
  19. Prognostic factors for resected non-small cell lung cancer with pN2 status: Implications for use of postoperative radiotherapy
  20. HSP90 inhibitors: Multi-targeted antitumor effects and novel combinatorial therapeutic approaches in cancer therapy
0